Soluble HLA-G molecules are increased in lymphoproliferative disorders
- 30 October 2003
- journal article
- Published by Elsevier in Human Immunology
- Vol. 64 (11), 1093-1101
- https://doi.org/10.1016/j.humimm.2003.08.345
Abstract
No abstract availableThis publication has 40 references indexed in Scilit:
- Sézary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokinesBlood, 2002
- Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 ProductionThe American Journal of Pathology, 2001
- Soluble human leukocyte antigen-G serum level is elevated in melanoma patients and is further increased by interferon-? immunotherapyCancer, 2001
- Detection of soluble HLA‐G molecules in plasma and amniotic fluidTissue Antigens, 1999
- p49, a putative HLA class I-specific inhibitory NK receptor belonging to the immunoglobulin superfamilyEuropean Journal of Immunology, 1998
- Endothelial cells in chorionic fetal vessels of first trimester placenta express HLA‐GEuropean Journal of Immunology, 1997
- HLA–G transcription studies during the different stages of normal and malignant hematopoiesisTissue Antigens, 1996
- DISTRIBUTION OF HLA‐G ALTERNATIVE mRNAs INCLUDING SOLUBLE FORMS IN NORMAL LYMPHOCYTES AND IN LYMPHOID CELL‐DERIVED LEUKEMIAInternational Journal of Immunogenetics, 1996
- Resistance of HLA-G and HLA-A2 Transfectants to Lysis by Decidual NK CellsCellular Immunology, 1994
- A Class I Antigen, HLA-G, Expressed in Human TrophoblastsScience, 1990